Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis

Chen, Jinghua1,2,3; Xia, Junxian1,2,3; Huang, Jiacheng1,2,3; Xu, Ruilian1,2,3

2020-06-03

10.1186/s12885-020-06983-2

BMC CANCER   影响因子和分区

1471-2407

1471-2407

Background18 F-FDG is a glucose analogue whose metabolic index SUV can effectively reflect the metabolic level of tumor microenvironment. Aspirin can affect the uptake of 18F-FDG by cancer cells, reducing the SUVmax value of primary tumors, exerting antitumor effect. This study aimed to evaluate the prognostic value of long-term aspirin and the relationship between aspirin intake and PET parameters value of primary tumor in non-small cell lung cancer (NSCLC).MethodsEighty-one NSCLC patients were recruited and divided into two groups: aspirin medication group and control group, who underwent surgery and had pathological diagnosis data between January 2012 and December 2016. Clinical characteristics were retrospective analyzed to evaluate the possibility of clinical prognosis, respectively. Kaplan-Meier curves and a Cox proportional hazard model were applied to evaluate the predictors of prognosis.ResultsThe PET/CT SUVmax of the primary tumor in the aspirin group was lower than that in the control group (P<0.05). Compared with the control group, the SUVmax, SUVmean and TLG of the primary tumor in aspirin group were lower, but the MTV value had no significant difference. Cox regression analysis showed that N stage and TNM stage were predictors of the prognosis. There was a significant difference in the use of aspirin in NSCLC patients.ConclusionAspirin can reduce SUVmax, SUVmean and TLG in primary tumor and aspirin can improve the prognosis of patients with NSCLC.

Aspirin SUVmax 18F-FDG Non-small cell lung cancer Prognosis

SCI

英语

第一 ; 通讯

Science, Technology & Innovation Commission of Shenzhen Municipality[JCYJ20160422144516003]

Oncology

Oncology

WOS:000540050300005

BMC

CLINICAL MEDICINE

Web of Science

1.Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen 518020, Peoples R China
2.Jinan Univ, Clin Med Coll 2, Shenzhen 518020, Peoples R China
3.Shenzhen Peoples Hosp, Dept Med Oncol, Shenzhen 518020, Peoples R China

Chen, Jinghua,Xia, Junxian,Huang, Jiacheng,et al. Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis[J]. BMC CANCER,2020,20(1).

Chen, Jinghua,Xia, Junxian,Huang, Jiacheng,&Xu, Ruilian.(2020).Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis.BMC CANCER,20(1).

Chen, Jinghua,et al."Effect of aspirin on PET parameters in primary non-small cell lung cancer and its relationship with prognosis".BMC CANCER 20.1(2020).